Morgan Keegan Raises PT on Sabra Health Care to $16

Juan Lopez , Benzinga Staff Writer

January 11, 2012 6:39am Comments

Morgan Keegan has raised the price target on Sabra Health Care (NASDAQ: SBRA) from $15 to $16 and maintains its Outperform rating.

Posted-In: Morgan Keegan Price Target Pre-Market Outlook Analyst Ratings

Need analyst data?
Click here to see licensing options.

Stock	Firm	Action	PT
SEDG	B of A Securities	Maintains	411.0
PTLO	Piper Sandler	Maintains	28.0
AOUT	Lake Street	Maintains	26.0
RAPT	Piper Sandler	Maintains	52.0
OCX	Lake Street	Maintains	6.0

1	RIVN, TSLA: Tesla Leads Used EV Sales In Record-Setting Week As Rivian Misses, Lyf...
2	LLY, NVTS: Benzinga Bulls And Bears: AMD, Apple, Eli Lilly — And Wall...
3	$ETH: Ethereum Creator Warns of Dangers From Companies Holding...
4	VOX, FCOM: AT&T, Verizon Dial Up Strong Q2 Results— E...
5	Shark Tank Star Recalls How A Nearly Bankrupt Tr...
6	TSLA: Elon Musk's Favorability Rating Among A...
7	As GPT-5 Launches, OpenAI Loyalists Pushed A...

1	Doctor Says He Sacrificed His 20s To Build Wealth — Now He's Asking Other...
2	Jeff Bezos Once Said Great Leaders Need More Sleep, Not More Hours — Amazon Fo...
3	Vance Predicts Numerous Indictments Following Trump's Treason Accusations A...
4	Bill Gates Drove His Daughter to Kindergarten Daily — Melinda Says Moms Starte...
5	AAPL: Apple's New Siri Voice-Control Feature Could Revolutionize User Experience
6	Binance Founder Zhao Seeks Pardon From Trump For Money-Laundering Violations
7	Trump on Pelosi's Investments: 'INSIDE INFORMATION,' 'Is...

Market Overview